Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma

Modern Pathology

Volumn 23, Issue 7, 2010, Pages 931-936

  Halat, Shams ^a   Eble, John N ^a   Grignon, David J ^a   Lopez Beltran, Antonio ^b   Montironi, Rodolfo ^c   Tan, Puay Hoon ^d   Wang, Mingsheng ^a   Zhang, Shaobo ^a   MacLennan, Gregory T ^e   Cheng, Liang ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

classification; differential diagnosis; fluorescent in situ hybridization (FISH); Kidney; molecular genetics; multilocular cystic renal cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER MORPHOLOGY; CHROMOSOME 3P; CHROMOSOME DELETION; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MULTILOCULAR CYSTIC RENAL CELL CARCINOMA; PRIORITY JOURNAL; CHROMOSOME 3; GENETICS; KIDNEY TUMOR; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED;

EID: 77954244750     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.78     Document Type: Article

References (39)

1. Eble JN. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press, Oxford University Press (distributor): Lyon, Oxford, 2004.
2. Halat SK, MacLennan GT. Multilocular cystic renal cell carcinoma. J Urol 2007;177:343.
3. Lopez-Beltran A, Scarpelli M, Montironi R, et al. 2004 WHO classification of the renal tumors of the adults. Eur Urol 2006;49:798-805.
4. Murphy WM, Grignon DJ, Perlman EJ. Tumors of the Kidney, Bladder, and Related Urinary Structures. American Registry of Pathology: Washington, DC, 2004.
5. Nassir A, Jollimore J, Gupta R, et al. Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature. Urology 2002;60:421-427.
6. Suzigan S, Lopez-Beltran A, Montironi R, et al. Multilocular cystic renal cell carcinoma: a report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol 2006;125:217-222.
7. Cheng L, Zhang S, MacLennan GT, et al. Molecular and cytogenetic insights into the pathogen-esis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol 2009;40:10-29.
8. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005;353:2477-2490.
9. Jones TD, Eble JN, Cheng L. Application of molecular diagnostic techniques to renal epithelial neoplasms. Clin Lab Med 2005;25:279-303.
10. Kovacs G, Erlandsson R, Boldog F, et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 1988;85:1571-1575.
11. Cheng L, MacLennan GT, Zhang S, et al. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Clin Cancer Res 2008;14:8087-8093.
12. Brunelli M, Eble JN, Zhang S, et al. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod Pathol 2003;16:1053-1059.
13. Brunelli M, Eccher A, Gobbo S, et al. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma. Mod Pathol 2008;21:1-6.
14. Brunelli M, Gobbo S, Cossu-Rocca P, et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol 2007;20:303-309.
15. Cheng L, Zhang S, MacLennan GT, et al. Interphase fluorescence in situ hybridization analysis of chromosome 12p abnormalities is useful for distinguishing epidermoid cysts of the testis from pure mature teratoma. Clin Cancer Res 2006;12: 5668-5672.
16. Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromo-some Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 2006;19:488-493.
17. Cossu-Rocca P, Eble JN, Zhang S, et al. Acquired cystic disease-associated renal tumors: an immunohisto-chemical and fluorescence in situ hybridization study. Mod Pathol 2006;19:780-787.
18. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008;32:1239-1245.
19. Gobbo S, Eble JN, Maclennan GT, et al. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol 2008;32:1780-1786.
20. Jones TD, Eble JN, Wang M, et al. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation. Cancer 2005;104:1195-1203.
21. Fallon KB, Palmer CA, Roth KA, et al. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 2004;63:314-322.
22. Eble JN, Bonsib SM. Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 1998;15:2-20.
23. Corica FA, Iczkowski KA, Cheng L, et al. Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup. J Urol 1999;161: 408-411.
24. Gobbo S, Eble JN, MacLennan GT, et al. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol 2008;32:1780-1786.
25. Amin MB, MacLennan GT, Gupta R, et al. Tubulocystic carcinoma of the kidney: clinicopatholo-gic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 2009;33: 384-392.
26. Barocas DA, Mathew S, DelPizzo JJ, et al. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU international 2007;99:290-295.
27. Sanjmyatav J, Rubtsov N, Starke H, et al. Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization. The Journal of Urology 2005;174:731-735.
28. Iliopoulos O, Eng C. Genetic and clinical aspects of familial renal neoplasms. Semin Oncol 2000;27:138-149.
29. Wagner JR, Linehan WM. Molecular genetics of renal cell carcinoma. Semin Urol Oncol 1996;14:244-249.
30. Young AC, Craven RA, Cohen D, et al. Analysis of VHL Gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma. Clin Cancer Res 2009;15:7582-7592.
31. Wu SQ, Hafez GR, Xing W, et al. The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma. Cancer 1996;77:1154-1160.
32. Beroud C, Fournet JC, Jeanpierre C, et al. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. Genes Chromosomes Cancer 1996;17:215-224.
33. Cairns P, Tokino K, Eby Y, et al. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res 1995;55:224-227.
34. Grady B, Goharderakhshan R, Chang J, et al. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma. J Urol 2001;166:1088-1092.
35. Kovacs G, Frisch S. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res 1989;49:651-659.
36. Mitsumori K, Kittleson JM, Itoh N, et al. Chromosome 14q LOH in localized clear cell renal cell carcinoma. J Pathol 2002;198:110-114.
37. Moch H, Presti Jr JC, Sauter G, et al. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 1996;56:27-30. (Pubitemid 26010380)
38. Presti Jr JC, Rao PH, Chen Q, et al. Histopatho-logical, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 1991;51: 1544-1552.
39. Schullerus D, Herbers J, Chudek J, et al. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. J Pathol 1997;183:151-155.